Like other drugs for heart failure, SGLT2 inhibitors were originally developed to lower blood sugar levels in patients with diabetes. But this drug soon found its way into the heart of clinics that ...

Cardiol Therapeutics Inc. President and CEO David Elsley discusses the rise in heart failure deaths among young adults on ...

The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) ...

but may include the drug's positive impacts on blood sugar, blood pressure, and inflammation, as well as direct effects on the heart muscle and blood vessels. The researchers said the reduction in all ...